An Investigator-initiated Trial to Assess the Effectiveness of Three Different Gummies (Curcumin Gummies, Vitamin C Gummies, and Vitamin B Complex Gummies) in Healthy Children

Sponsor
NovoBliss Research Pvt Ltd (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05775237
Collaborator
(none)
48
1
3
1
47.1

Study Details

Study Description

Brief Summary

An Open-Label, Three-Arm, Parallel, Investigator-Initiated Trial of Three Different Gummies (Curcumin Gummies, Vitamin C Gummies, and Vitamin B Complex Gummies) in Healthy Children.

A sufficient number (maximum of 48, (16 children/arm)) of children subjects will be recruited to ensure a total of 45 subjects (15 children /arm) complete the study.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Curcumin Gummies
  • Dietary Supplement: Vitamin C Gummies
  • Dietary Supplement: Multivitamin Gummies
N/A

Detailed Description

Qualifying siblings within the same household are permitted in the study. The potential subjects will be screened as per the inclusion and exclusion criteria only after obtaining written parental informed consent and from the subjects and subjects' legal parent/legal guardian.

The subject's parents will be instructed to visit the facility as per the below visits:
  • Visit 01 (Day 01): Screening, Enrolment Visit

  • Visit 02 (Day 30): Evaluations, End of Study Visit Subjects will be pre-screened by the screening department of NovoBliss Research. Subjects will be called on the telephone by the recruiting department prior to the enrolment visit.

Assessment of safety, efficacy and organoleptic properties will be done on Day 01 as a baseline before test product usage to Day 30 after test product usage.

Reduction in frequency of getting the sickness. Consumer feedback-subjective questionnaires - Health Questionnaire Product Perception Questionnaire - Organoleptic parameters.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
48 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
An Open-Label, Three-Arm, Parallel, Investigator-Initiated Trial of clinical studyAn Open-Label, Three-Arm, Parallel, Investigator-Initiated Trial of clinical study
Masking:
None (Open Label)
Masking Description:
This Study is Open-label
Primary Purpose:
Supportive Care
Official Title:
An Open-Label, Three-Arm, Parallel, Investigator-Initiated Trial of Three Different Gummies (Curcumin Gummies, Vitamin C Gummies, and Vitamin B Complex Gummies) in Healthy Children
Anticipated Study Start Date :
Mar 15, 2023
Anticipated Primary Completion Date :
Apr 15, 2023
Anticipated Study Completion Date :
Apr 15, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Curcumin Gummies

Curcumin Gummies contain energy, dietary fiber, sugar, total carbohydrate, protein, fat, and curcumin.

Dietary Supplement: Curcumin Gummies
Chew gummies thoroughly and completely before swallowing.
Other Names:
  • curcumin
  • Experimental: Vitamin C Gummies

    Vitamin C Gummies contain Vitamin C and Zinc

    Dietary Supplement: Vitamin C Gummies
    Chew gummies thoroughly and completely before swallowing.
    Other Names:
  • Vitamin C
  • Experimental: Multivitamin Gummies

    Multivitamin Gummies contain energy, dietary fiber, sugar, total carbohydrate, protein, fat, sodium, Vitamin C, Vitamin E, pantothenic acid, Zinc, iodine, Vitamin A, Magnesium, Folate, Vitamin D, Vitamin 12

    Dietary Supplement: Multivitamin Gummies
    Chew gummies thoroughly and completely before swallowing.
    Other Names:
  • Multivitamin
  • Outcome Measures

    Primary Outcome Measures

    1. Assessment of Safety [Day 01 before test product usage to 30 Day after Test product usage]

      To evaluate the Safety of Test Product by using subject perception questionnaires regarding Health

    2. Assessment of Efficacy [Day 01 before test product usage to 30 Day after Test product usage]

      To evaluate the Efficacy of Test Product by using subject perception questionnaires regarding Health

    3. Assessment of Organoleptic properties [30 Day after usage of Test product]

      To evaluate the Organoleptic properties of Test Product by using subject perception questionnaires regarding Test Product

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    2 Years to 12 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. Age: 02 to 12 years old (both inclusive) at the time of parental consent.

    2. Overall good health of the child subject is determined by medical examination and history evaluated by the Investigator.

    3. Subject's mother/legal guardian, preferably willing to give a voluntary written informed consent i.e. parental informed consent form and agree to complete study activities and come for regular follow-up with a subject.

    4. The subject's mother/legal guardian for their child is preferably willing to abide by and comply with the study protocol.

    5. The subject should not participate in any other clinical study during participation in the current study

    6. Subject are agreed to maintain current level of activity through the study.

    Exclusion Criteria:
    1. Subjects with known history of allergies or specific allergic reactions upon using curcumin, vitamins, zinc, pantothenic acid.

    2. Subjects who are currently enrolled in an active investigational study or have participated in an investigational study within 30 days prior to enrolment.

    3. Subjects, who in the opinion of the Investigator or the Expert physician are not eligible for enrolment in the study.

    4. Subject who are unwilling to provide consent.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 NovoBliss Research Pvt Ltd Gandhinagar Gujarat India 382421

    Sponsors and Collaborators

    • NovoBliss Research Pvt Ltd

    Investigators

    • Principal Investigator: Dr. Chitra Prajapati, MBBS, Principal Investigator

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dr Chitra Prajapati, Principal Investigator, NeighbourCare Clinics
    ClinicalTrials.gov Identifier:
    NCT05775237
    Other Study ID Numbers:
    • NB230001-NCP
    First Posted:
    Mar 20, 2023
    Last Update Posted:
    Mar 22, 2023
    Last Verified:
    Mar 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 22, 2023